| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.39 | 0.004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |